Cellipont Bioservices opened a new, state-of-the-art cell therapy manufacturing facility in The Woodlands, Texas, and needed a modern digital foundation to support high-quality, compliant, and scalable operations. Their previous approach relied on spreadsheets and paper-based processes, which created risks across batch records, QA review, inventory management, and sample and data tracking. To meet current and future regulatory expectations and increase operational efficiency, Cellipont selected L7|ESP® with embedded L7 MES as the core of its digital manufacturing ecosystem.
With L7 MES, Cellipont digitalized and templatized complex batch record workflows, established review-by-exception manufacturing, automated calculations and barcode-driven steps, and centralized documentation for transparency and traceability. The platform now supports efficient QA review, automated sample tracking, integrated label printing, streamlined task management, and improved visibility across manufacturing processes.
L7|ESP enables Cellipont to optimize quality review, inventory management, and operational throughput while creating a connected, contextualized data foundation. This unified approach strengthens day-to-day manufacturing and enhances connectivity, communication, and tech transfer between teams and sites, positioning Cellipont for long-term scalability and excellence in cell therapy production.
To access this resource, please make sure to accept cookies.